Skip to Content

Sonova Holding AG SONVF

Morningstar Rating
$307.50 +11.33 (3.82%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

SONVF is trading at a 145% premium.
Price
$308.26
Fair Value
$379.62
Uncertainty
Medium
1-Star Price
$136.72
5-Star Price
$483.76
Economic Moat
Nrbz
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if SONVF is a good fit for your portfolio.

Trading Information

Previous Close Price
$296.17
Day Range
$307.50307.67
52-Week Range
$230.16334.50
Bid/Ask
$291.55 / $307.08
Market Cap
$18.33 Bil
Volume/Avg
49 / 304

Key Statistics

Price/Earnings (Normalized)
23.26
Price/Sales
4.49
Dividend Yield (Trailing)
1.57%
Dividend Yield (Forward)
1.57%
Total Yield
1.77%

Company Profile

Sonova is one of the world's manufacturers and distributors of hearing aids. The company is based in Switzerland and distributes its products in more than 100 countries through its internal sales team and independent retailers. It also sells cochlear implants through its advanced bionics subsidiary and recently acquired Sennheiser's consumer division to expand into audio technologies.
Sector
Healthcare
Industry
Medical Devices
Stock Style Box
Large Core
Total Number of Employees
18,151

Competitors

Valuation

Metric
SONVF
GN
DEMANT
Price/Earnings (Normalized)
23.2623.2722.49
Price/Book Value
6.702.586.06
Price/Sales
4.491.392.53
Price/Cash Flow
20.789.8613.11
Price/Earnings
SONVF
GN
DEMANT

Financial Strength

Metric
SONVF
GN
DEMANT
Quick Ratio
1.020.410.84
Current Ratio
1.450.591.37
Interest Coverage
23.783.996.91
Quick Ratio
SONVF
GN
DEMANT

Profitability

Metric
SONVF
GN
DEMANT
Return on Assets (Normalized)
10.91%1.71%8.40%
Return on Equity (Normalized)
26.88%5.73%28.27%
Return on Invested Capital (Normalized)
17.63%3.07%12.19%
Return on Assets
SONVF
GN
DEMANT
See how this stock stacks up to its competitors with Morningstar Investor

Medical Devices Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Abbott Laboratories
ABT
YjrvpkvGjnrbg$182.1 Bil
Stryker Corp
SYK
HxrzwkfprkSkrtk$127.5 Bil
Boston Scientific Corp
BSX
JffkpbnvFwgzj$113.8 Bil
Medtronic PLC
MDT
FypcphvFbrccz$104.2 Bil
Edwards Lifesciences Corp
EW
WmttwqnpdSwljcs$52.6 Bil
DexCom Inc
DXCM
GdxgdbsppBgbm$45.4 Bil
Koninklijke Philips NV ADR
PHG
TgkczgzvFdcdzv$24.2 Bil
Zimmer Biomet Holdings Inc
ZBH
YwpglhpktCczm$22.8 Bil
Steris PLC
STE
LvhwrftdTdwmf$22.6 Bil
Align Technology Inc
ALGN
NxyvhwtksMntmlxn$18.9 Bil

Sponsor Center